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Strengths and limitations of this study
 ► The nation-wide study on process indicators of pri-
mary healthcare (PHC) covered all general medical 
practices in Hungary responsible for the provision to 
adults, avoided selection bias.
 ► Our investigation could estimate the population-lev-
el impact of the general practitioner (GP) gender 
effect.
 ► Although the analyses were controlled for several 
factors (GP age; patient age, gender, relative edu-
cation; and practice size, types of settlement and 
regional location) influencing the quality of PHC, by 
involving other potential confounding factors (such 
as onset/duration of a chronic diseases, prefer-
ences and conditions of patients), reliability of our 
estimations for risks and impacts could be further 
improved.
AbStrACt
Objectives The objectives of our study were (1) to 
investigate the association between gender of the general 
practitioner (GP) and the quality of primary care in Hungary 
with respect to process indicators for GP performance and 
(2) to assess the size of the gender impact.
Study design A nation-wide cross-sectional study was 
performed in 2016.
Setting and participants The study covered all general 
medical practices in Hungary (n=4575) responsible for the 
provision of primary healthcare (PHC) for adults. All GPs in 
their private practices are solo practitioners.
Main outcome measures Multilevel logistic regression 
models were used to analyse the association between GP 
gender and process indicators of PHC, and attributable 
proportion (AP) was calculated.
results 48% of the GPs (n=2213) were women in 
the study. The crude rates of care provided by female 
GPs were significantly higher for seven out of eight 
evaluated indicators than those provided by male GPs. 
Adjusted for practice, physician and patient factors, 
GP gender was associated with the haemoglobin A1c 
(HbA1c) measurement: OR=1.18, 95% CI (1.14 to 1.23); 
serum creatinine measurement: OR=1.14, 95% CI (1.12 
to 1.17); lipid measurement: OR=1.14, 95% CI (1.11 to 
1.16); eye examination: OR=1.06, 95% CI (1.03 to 1.08); 
mammography screening: OR=1.05, 95% CI (1.03 to 1.08); 
management of patients with chronic obstructive pulmonary 
disease: OR=1.05, 95% CI (1.01 to 1.09) and the composite 
indicator: OR=1.08, 95% CI (1.07 to 1.1), which summarises 
the number of care events and size of target populations of 
each indicator. The AP at the specific indicators varied from 
0.97% (95% CI 0.49% to 1.44%) of influenza immunisation 
to 8.04% (95% CI 7.4% to 8.67%) of eye examinations.
Conclusion Female GP gender was an independent 
predictor of receiving higher quality of care. The actual 
size of the gender effect on the quality of services seemed 
to be notable. Factors behind the gender effect should 
receive more attention in quality improvement particularly 
in countries where the primary care is organised around 
solo practices.
IntrOduCtIOn
The gender composition of physicians has 
changed in the last decades in all organisation 
for economic co-operation and development 
(OECD) countries. The proportion of female 
physicians has increased from 38% (in 2000) 
to 46% (in 2015), and this trend is expected 
to continue.1 The Central and Eastern Euro-
pean countries showed the highest share of 
female physicians in 2015. Extremes of this 
share were observed in Latvia (74.4%) and in 
Estonia (74.6%), but the strongest growing 
trend was in the Netherlands, where the 
proportion of female physicians increased 
from 35.3% to 52.6% from 2000 to 2015. 
However, changes in gender proportions are 
not homogeneous in the different medical 
specialties; some, such as family medicine, are 
more affected.1–4
According to the international litera-
ture, there is solid evidence that the physi-
cian’s gender influences the effectiveness 
of medical care in primary healthcare 
(PHC).5–9 Female physicians in primary care 
tend to deliver more preventive services,10–18 
they have better adherence to guidelines 
of chronic diseases8 19 and they achieve 
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better intermediate treatment outcomes (blood pres-
sure, haemoglobin A1c (HbA1c) and cholesterol level), 
compared with their male colleagues.20 21
Several arguments could partially explain the existing 
differences between the quality of services provided by the 
two genders. Female physicians more often use patient-cen-
tred approach; moreover, they effectively facilitate patient 
participation in the medical exchange.8 22 23 According 
to studies in clinical practice, female physicians spend 
significantly more time with their patients and have longer 
consultations.6 24–26 Others have underlined the signifi-
cance of the patient-centred communication style, which 
is more frequently applied by female physicians.8 27 28 
Empathy is a further aspect of physicians’ behaviour asso-
ciated with better patient compliance and outcomes in 
chronic disease care23 29–31 and a higher level of empathy is 
a well-known characteristic of women.32 33 Additionally, the 
level of empathy seems to have an impact on career choices; 
individuals with higher empathy tend to prefer the primary 
care specialty.30 33 34 Similar specialty preference was found 
among both medical students and physicians.30
The association between the gender of the provider 
(especially general practitioners (GPs)) and the effective-
ness of the service is well demonstrated in many settings, 
but the exploration of how the gender of the physician 
actually affects the care practices and assessments of the 
size of the effect are insufficient.
Hungary provides an ideal field to examine the gender 
effect at the level of primary care in detail. The country has 
one of the highest shares of female physicians of general 
medicine and paediatrics, with a total share of 55.9% in 
20151 and 56.2% in 2017.35 In Hungary, the gender of 
the GP can be used as a potential factor affecting general 
medical practice (GMP)-level performance indicators 
because each individual GP works in their own primary 
care district with a territorial supply obligation (municipal-
ities are responsible for the provision of primary care for 
the local population within their territory). Since 2009, the 
performance of providers has been monitored for quality 
indicators by the National Institute of Health Insurance 
Fund Management (NIHIFM), which have contracts with 
all GPs in the country. This monitoring exclusively applies 
process indicators to assess the quality of chronic disease 
management in primary care. The evaluation of GMPs and 
the provision of financial incentives are based on reaching 
desired target values for these indicators.36
The objectives of our study were (1) to investigate the 
association between GP gender and the quality of primary 
care with respect to various process indicators for GMP 
performance and (2) to assess the size of the gender impact.
MethOdS
Setting
The healthcare system in Hungary is based on compulsory 
health insurance with universal coverage. Primary care 
services are provided by GPs working in solo practices; 
therefore, one GMP is owned and operated by one GP. 
In vacant GMPs, the services are provided by temporary 
GPs with restricted availability in time and place. The GPs 
are contracted with the NIHIFM, and they have territorial 
supply obligation, but patients can choose and change 
their primary care provider without any restriction.37
Study design
A nation-wide cross-sectional study was performed, which 
covered all GMPs in Hungary responsible for the adult 
primary care in 2016 (n=4852). Demographic data of 7 
207 186 clients (above 18 years) and 4575 GPs, the GMPs’ 
organisational characteristics and data on performance 
indicators for GMPs were provided by NIHIFM. Vacant 
GMPs without a permanent GP during the study period 
(5.71%, n=277) were excluded, as this secondary analysis 
aimed to evaluate the influence of GPs’ gender on PHC 
indicators.
Patient and public involvement
Patients and the public were not involved in this study.
Patient-level, physician-level and organisational 
characteristics of GMPs
Patient-specific and GMP-specific data were provided by 
NIHIFM. The number of adults registered in each GMP 
was determined by gender and age groups of 18–19, 
20–24, 25–29, 30–34, 35–39, 40–44, 45–49, 50–54, 55–59, 
60–64, 65–69, 70–74, 75–79, 80–84, 85–89, and 90 years 
and above in the database. The age group of 65–69 (and 
60–64 where 65 years and above patients were not avail-
able) was used as a reference. The age of the GP was a 
continuous variable. The male gender of GPs and patients 
were used as a reference in the analyses.
GMPs were categorised by the practice size (number of 
insured people registered in each GMP as follows:<800, 
801–1200, 1201–1600, 1601–2000 and >2000; the cate-
gories are defined by NIHIFM), and types of settlement 
(rural and urban). The regional location of each GMP 
was described by the county (Baranya, Bács-Kiskun, Békés, 
Borsod-Abaúj-Zemplén, Csongrád, Fejér, Győr-Moson-So-
pron, Hajdú-Bihar, Heves, Komárom-Esztergom, Nógrád, 
Pest, Somogy, Szabolcs-Szatmár-Bereg, Jász-Nagykun-
Szolnok, Tolna, Vas, Veszprém and Zala counties) and the 
capital city (Budapest). The practice size of 1201–1600, 
the rural settlement and Budapest were used as reference 
categories.
The relative education was used to indicate the educa-
tional attainment of adults registered in each GMP. This 
indicator was calculated using gender, age group (7–19, 
20–24, 25–29, 30–34, 35–39, 40–44, 45–49, 50–54, 55–59, 
60–64, 65–69, 70–74, 75–79, 80–84, 85–89 and 90 years 
and above), and settlement-specific data from 2011 
Hungarian Census data provided by the Hungarian 
Central Statistical Office. The summarised length of 
education was calculated for each settlement. The 
expected number of school years was determined for 
adults in each settlement by the demographic character-
istics of the settlement and the national reference values. 
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Table 1 Definition and the target group of the studied PHC indicators
Indicator Target group Definition
Influenza 
immunisation
Patients over 65 years Proportion of PHC patients, age 65 years and older, who received an 
influenza immunisation in the previous 12 months
Mammography 
screening
45–65 years-old female 
PHC patients
Proportion of female PHC patients, age 45–65 years, who received 
mammography in the previous 24 months
Serum creatinine 
measurement
Patients who redeemed 
antihypertensive drug 
at least four times in 
the previous 12 months 
(considered as patients with 
hypertension)
Proportion of PHC patients with hypertension screened for serum creatinine 
in the previous 12 months
Lipid measurement Patients who redeemed 
antihypertensive drug 
at least four times in 
the previous 12 months 
(considered as patients with 
hypertension)
Proportion of PHC patients with hypertension and/or diabetes screened for 
lipid abnormalities in the previous 12 months
Beta-blocker 
application
Patients with AMI or CABG 
or PTCA
Proportion of patients with AMI, CABG or PTCA who used beta-blockers in 
the previous 12 months
HbA1c 
measurement
ATC A10 drug users Proportion of PHC patients with diabetes mellitus screened for HbA1c in the 
previous 12 months
Eye examination ATC A10 drug users Proportion of PHC patients with diabetes mellitus who attended eye 
examination in the previous 12 months
Management of 
COPD
ATC R03 drug users and 
patients with COPD
Proportion of PHC patients with COPD who attended pulmonary function 
testing in the previous 12 months
Composite indicator Total number of patients of 
each studied indicator
Proportion of PHC patients provided with recommended care; a general 
indicator of performance of GMP by summarising the number of care events 
and size of target populations of each studied indicator
AMI, acute myocardial infarction; CABG, coronary artery bypass grafting; COPD, chronic obstructive pulmonary disease; GMP, general 
medical practice; HbA1c, haemoglobin A1c; PHC, primary healthcare; PTCA, percutaneous transluminal coronary angioplasty.
The ratio of observed and expected values, representing 
the settlement-specific relative education, was used to 
express the relative education of adults living in a certain 
settlement compared with the national reference level. A 
weighted settlement-specific relative education variable 
was calculated for GMPs providing care for patients from 
more than one settlement.38
Performance indicators for GMPs
Each routine indicator of NIHIFM on immunisation, 
cancer screening and chronic disease management were 
used to assess the performance of GMPs: (1) proportion 
of patients with influenza immunisation; (2) proportion 
of patients who participated in screening mammography; 
(3) proportion of patients with hypertension with serum 
creatinine measurements; (4) proportion of patients 
with diabetes and/or hypertension with lipid profile 
measurements; (5) proportion of beta-blocker use among 
patients with ischaemic heart disease; (6) proportion of 
patients with diabetes with HbA1c measurements; (7) 
proportion of patients with diabetes who attended eye 
examination and (8) proportion of patients with chronic 
obstructive pulmonary disease (COPD) who participated 
in pulmonary functional testing. A composite indicator 
(proportion of patients who received recommended 
care) was calculated by summarising the number of care 
events and the size of the target groups by each studied 
indicator. Indicators reflect the proportion of patients 
who received the care in each GMP. Details about the 
target groups and definitions of the assessed process indi-
cators are shown in table 1.
Statistical analysis
Differences between baseline characteristics of GMPs 
were evaluated by the Pearson χ2 test for categorical vari-
ables and two-sample t-test for continuous variables.
We used multilevel logistic regression models because 
of the binary outcome variables and in order to account 
for the clustering effect of patients within physicians. The 
models were adjusted for characteristics of patients (age 
and gender), GPs (age) and GMPs (practice size, types 
of settlement, geographical location and relative educa-
tion) to assess the effect of the gender of the GP on their 
performance in case of each indicator. ORs with the corre-
sponding 95% CIs, and robust standard errors were esti-
mated. We presented intraclass correlation coefficient, 
which shows the proportion of total variance explained by 
the physician as grouping factor. The Hosmer-Lemeshow 
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test was used to determine the goodness of fit of the 
model (by comparing predicted and observed outcomes 
in deciles of predicted risk), which verified the adequacy 
of the model.
We calculated the missed care events, that is the number 
of care events not meeting the number of events which 
would be expected if the care was provided by female GP. 
The expected number of care events was calculated for 
GMPs with male GPs, using the demographic composi-
tion of adults belong to GMPs and considering female 
GPs as a reference, to describe the gender impact on 
service use in the whole country. Both observed and 
expected number of events were summarised for the 
whole country. The differences between the summarised 
observed and expected number of care events were calcu-
lated for GMPs with male GPs to quantify the differences 
in the number of care events compared with female GPs. 
Attributable proportion (AP) with 95% CI was also calcu-
lated by the summarised number of events to show the 
percentage of care events that can be attributed to the 
male GP gender.
Statistical significance was considered p<0.05. Statistical 
analyses were performed using STATA IC V.13.0 software.
reSultS
descriptive statistics
The studied 4575 GPs (providing care for adults) 
consisted of 2213 (48.4%) women, and 2362 (51.6%) 
men (p<0.001). Female GPs were younger (55.3 years vs 
57.8 years; p<0.001), more likely to work in urban regions 
(75.8% vs 62.0%; p<0.001) and had smaller sized GMPs 
(p<0.001). Patients of female physicians were more likely 
to be female (54.6% vs 52.31%; p<0.001). The mean 
relative education was higher in GMPs with female GPs 
(1.026 vs 0.989; p<0.001). The patient, physician and 
organisational characteristics of GMPs are summarised 
in table 2.
Female GPs were younger. In the group of female 
GPs under 55 years and male GPs above 65 years were 
over-represented (figure 1).
According to the crude values of the PHC indicators 
(aggregated by the gender of the GP), statistically signif-
icant differences were found between male and female 
physicians. Patients of female GPs were more likely to 
have had serum creatinine (70.9% vs 66.5%; p<0.001), 
lipid (64.5% vs 59.7%; p<0.001) and HbA1c (80.6% vs 
76.8%; p<0.001) measurements; ophthalmological exam-
inations (41.3% vs 38.2%; p<0.001); and mammography 
screening (46.7% vs 44.7%; p<0.001). They were also 
more likely to be managed properly in cases of COPD 
(79.1% vs 77.3%; p<0.001). Although there was statisti-
cally significant differences between genders related to 
vaccination against influenza (p=0.004), the size of differ-
ence was negligible (20.1% vs 19.9%). Patients with male 
GPs were more likely to receive beta-blockers (52.3% vs 
53.5%; p<0.001) (table 3).
Multilevel analyses
According to the multilevel logistic regression analysis, 
patients of female GPs were significantly more likely to 
receive care according to guidelines. The female gender 
of GPs was associated with hypertension and diabetes 
care-related indicators (HbA1c measurement, serum 
creatinine measurement, lipid measurement and eye 
examination), mammography screening, management 
of COPD patients and the composite indicator. No asso-
ciation was observed between influenza immunisation, 
beta-blocker application and GP gender. The proportion 
of total variability attributable to physician after adjusting 
for characteristics of physician, patient and practice 
varied between 2.4% and 17.9% across the indicators 
(table 4). Gender had one of the strongest effects among 
all studied variables on hypertension and diabetes care 
indicators (HbA1c, serum creatinine and lipid measure-
ment). Results of the regression models are presented in 
Supplementary Table 1-2.
Population-level impact
Overall, 5.9% (95% CI 5.77% to 6.02%) of missed care 
events are attributable to male GP gender, which corre-
sponds to 144 871 care events in the country per year. 
Restricting this summary to indicators with a significant 
association with GP gender (omitting influenza vaccina-
tion and beta-blocker application), the missed number of 
interventions was 144 373.
Compared with the GMPs with female GPs, the highest 
AP was observed for lipid measurement (AP=7.93%, 
95% CI 7.71% to 8.16%), whereas the lowest AP was 
observed for influenza immunisation (AP=0.97%, 95% CI 
0.49% to 1.44%). A notable percentage of missed care 
events was attributed to GPs’ male gender in the case 
of serum creatinine measurement (AP=6.4%, 95% CI 
6.18% to 6.61%), eye examinations (AP=8.04%, 95% CI 
7.4% to 8.67%) and HbA1c measurements (AP=5.09%, 
95% CI 4.65% to 5.54%). Mammography screening was 
not performed for 4.36% (95% CI 4.00% to 4.71%) of 
women in the target group, whereas COPD management 
was missed for 2.33% (95% CI 1.61% to 3.04%) of patients 
if the GP was male. Only beta-blocker application showed 
more care events that were attributed to male gender of 
GPs (AP=2.42%, 95% CI 1.53% to 3.31%) (table 5).
dISCuSSIOn
Main findings
Our results showed that GP gender was independently 
associated with quality of care with respect to process 
indicators for cancer screening and the management of 
chronic diseases (hypertension, diabetes and COPD). 
Patients of female GPs were more likely to have their 
HbA1c levels, serum creatinine, lipid measured, as well 
as their ophthalmological examination and pulmonary 
function testing implemented for monitoring purposes. 
Moreover, female patients of female GPs received signifi-
cantly more mammography. Gender effect seems to have 
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Table 2 Patient-level, physician-level and organisational characteristics of GMPs
All GMPs GMPs with male GPs GMPs with female GPs P value
Number of GMPs n=4575 n=2362 (51.6%) n=2213 (48.4%)
Age of GP, mean (SD) 56.6 (11.2) 57.8 (11.3) 55.3 (10.9) <0.001
Number GMPs’ patients
  Male 3 360 154 (46.6%) 1 794 560 (47.7%) 1 565 594 (45.5%) <0.001
  Female 3 847 032 (53.4%) 1 968 309 (52.3%) 1 878 723 (54.6%)
  Total 7 207 186 3 762 869 3 444 317
Age (years) groups of patients
  18–19 121 802 (1.69%) 67 609 (1.8%) 54 193 (1.57%) <0.001
  20–24 483 058 (6.7%) 256 773 (6.82%) 226 285 (6.57%)
  25–29 539 957 (7.49%) 280 817 (7.46%) 259 140 (7.52%)
  30–34 553 972 (7.69%) 283 279 (7.53%) 270 693 (7.86%)
  35–39 690 907 (9.59%) 352 765 (9.37%) 338 142 (9.82%)
  40–44 752 110 (10.44%) 389 203 (10.34%) 362 907 (10.54%)
  45–49 647 431 (8.98%) 339 710 (9.03%) 307 721 (8.93%)
  50–54 534 270 (7.41%) 284 021 (7.55%) 250 249 (7.27%)
  55–59 561 965 (7.8%) 298 506 (7.93%) 263 459 (7.65%)
  60–64 665 236 (9.23%) 347 758 (9.24%) 317 478 (9.22%)
  65–69 542 777 (7.53%) 283 530 (7.53%) 259 247 (7.53%)
  70–74 416 851 (5.78%) 215 507 (5.73%) 201 344 (5.85%)
  75–79 316 345 (4.39%) 165 255 (4.39%) 151 090 (4.39%)
  80–84 213 912 (2.97%) 111 762 (2.97%) 102 150 (2.97%)
  85–89 117 420 (1.63%) 61 119 (1.62%) 56 301 (1.63%)
  >90 49 322 (0.68%) 25 378 (0.67%) 23 944 (0.7%)
Relative education, mean 
(SD)
1.000 (0.1) 0.989 (0.2) 1.026 (0.1) <0.001
Types of settlement
  Urban 3143 (68.7%) 1465 (62.0%) 1678 (75.8%) <0.001
  Rural 1432 (31.3%) 897 (37.9%) 535 (24.2%)
GMP size (number of patients)
  <800 126 (2.8%) 66 (2.9%) 60 (2.7%) <0.001
  801–1200 646 (14.1%) 322 (13.6%) 324 (14.6%)
  1201–1600 1464 (32.0%) 690 (29.2%) 774 (34.9%)
  1601–2000 1415 (30.9%) 742 (31.4%) 673 (30.4%)
  >2000 924 (20.2%) 542 (22.9%) 382 (17.3%)
GMP, general medical practice; GP, general practitioner.
a clinical relevance mostly on hypertension and diabetes 
care-related indicators, considering both the higher effect 
of the GP's gender (HbA1c measurement: OR=1.18, 
95% CI 1.14 to 1.23, serum creatinine: OR=1.14, 95% CI 
1.12 to 1.17 and lipid measurement: OR=1.14, 95% CI 
1.11 to 1.16) and size of the affected population compared 
with other indicators (mammography screening, eye 
examination and management of COPD) where we also 
found statistically significant differences. A lack of gender 
influence was observed only for influenza immunisation 
and for beta-blocker usage.
The size of this gender effect proved to be notable. 
A high proportion (ARtotal=5.9%) of missed care events 
could be attributed to this gender effect. More than 144 
000 care events per year were missed (out of 2 600 827 
expected events) due to gender effect among patients 
of male GPs in Hungary. Primarily, missed lipid (59 723 
missed laboratory investigations) and serum creatinine 
measurements (52 130 missed laboratory investigations) 
were responsible for this impact. Missed examinations 
among patients with diabetes mellitus (9801 missed 
HbA1c measurements and 7686 missed eye examinations) 
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Figure 1 The age and gender distribution of Hungarian GPs 
responsible for the adult primary healthcare in 2016. GPs, 
general practitioners.
Ta
b
le
 3
 
Th
e 
nu
m
b
er
 o
f p
at
ie
nt
s 
re
ce
iv
ed
 t
he
 c
ar
e,
 t
he
 n
um
b
er
 o
f p
eo
p
le
 in
 t
he
 t
ar
ge
t 
gr
ou
p
s 
an
d
 t
he
 p
ro
p
or
tio
n 
of
 p
at
ie
nt
s 
re
ce
iv
ed
 t
he
 c
ar
e 
in
 2
01
6 
fo
r 
th
e 
w
ho
le
 
co
un
tr
y 
b
y 
ge
nd
er
 o
f G
P
s 
w
ith
 9
5%
 C
Is N
um
b
er
 o
f 
p
at
ie
nt
s 
re
ce
iv
ed
 t
he
 c
ar
e
N
um
b
er
 o
f 
p
eo
p
le
 in
 t
ar
g
et
 g
ro
up
P
ro
p
o
rt
io
n 
o
f 
p
at
ie
nt
s 
re
ce
iv
ed
 t
he
 c
ar
e
M
al
e 
G
P
s
Fe
m
al
e 
G
P
s
M
al
e 
G
P
s
Fe
m
al
e 
G
P
s
M
al
e 
G
P
s
Fe
m
al
e 
G
P
s
P
 v
al
ue
In
flu
en
za
 im
m
un
is
at
io
n
17
2 
15
0
15
9 
89
3
86
5 
18
7
79
6 
38
0
19
.9
%
(1
9.
8–
19
.9
)
20
.1
%
(1
9.
9–
20
.2
)
0.
00
4
M
am
m
og
ra
p
hy
 s
cr
ee
ni
ng
30
4 
90
7
29
9 
13
7
68
1 
14
1
64
0 
29
3
44
.7
%
(4
4.
6–
44
.9
)
46
.7
%
(4
6.
5–
46
.9
)
<
0.
00
1
S
er
um
 c
re
at
in
in
e 
m
ea
su
re
m
en
t
81
4 
81
9
78
5 
95
0
1 
22
5 
15
8
1 
10
8 
16
8
66
.5
%
(6
6.
4–
66
.6
)
70
.9
%
(7
0.
8–
71
.0
)
<
0.
00
1
Li
p
id
 m
ea
su
re
m
en
t
75
2 
73
7
73
5 
50
2
1 
26
1 
49
0
1 
13
9 
84
3
59
.7
%
(5
9.
6–
59
.8
)
64
.5
%
(6
4.
4–
64
.6
)
<
0.
00
1
B
et
a-
b
lo
ck
er
 a
p
p
lic
at
io
n
48
 2
02
42
 1
84
90
 1
12
80
 7
23
53
.5
%
(5
3.
2–
53
.8
)
52
.3
%
(5
1.
9–
52
.6
)
<
0.
00
1
H
b
A
1c
 m
ea
su
re
m
en
t
19
2 
37
0
17
9 
47
4
25
0 
57
5
22
2 
69
0
76
.8
%
(7
6.
6–
76
.9
)
80
.6
%
(8
0.
4–
80
.8
)
<
0.
00
1
E
ye
 e
xa
m
in
at
io
n
95
 6
17
91
 9
95
25
0 
57
5
22
2 
69
0
38
.2
%
(3
7.
9–
38
.4
)
41
.3
%
(4
1.
1–
41
.5
)
<
0.
00
1
M
an
ag
em
en
t 
of
 C
O
P
D
75
 1
54
69
 8
35
97
 2
13
88
 3
45
77
.3
%
(7
7.
1–
77
.6
)
79
.1
%
(7
8.
8–
79
.3
)
<
0.
00
1
C
om
p
os
ite
 in
d
ic
at
or
2  
45
5 
95
6
2 
36
3 
97
0
4 
72
1 
45
1
4 
29
9 
13
2
52
.0
%
(5
1.
9–
52
.1
)
54
.9
%
(5
4.
9–
55
.0
)
<
0.
00
1
C
O
P
D
, c
hr
on
ic
 o
b
st
ru
ct
iv
e 
p
ul
m
on
ar
y 
d
is
ea
se
; G
P
s,
 g
en
er
al
 p
ra
ct
iti
on
er
s;
 H
b
A
1c
, h
ae
m
og
lo
b
in
 A
1c
.
and missed breast cancer screenings (13 285 screening 
tests) had a secondary, but significant, contribution.
Comparison with other studies
Others found similar gender differences in the manage-
ment of diabetes8 20 21 39 40 and cancer8 41 screening. In addi-
tion, several studies have found an association between 
the management of hypertension and the gender of the 
physician. Female GPs tend to reach the blood pressure 
and lipid-level treatment goals more often42 43 and tend to 
focus better on cardiovascular risk factor control.15 39 42 43 
Altogether, a positive association was observed between 
female gender and better quality of PHC in our investi-
gation, in line with international experiences. Besides, 
our findings are consistent with other studies found that 
relatively low percentage of the variance is attributable to 
physicians on process measures after adjusting for charac-
teristics of the physician, patient and practice.44 45
Strength and limitations
A strength of this study was that it covered the entire 
Hungarian population, avoiding selection bias in the 
analysis of the association between GP gender and PHC 
indicators and resulting in the representativeness of our 
results for the whole Hungarian PHC population. As a 
consequence, the main strength of our investigation was 
that it could estimate the population-level impact of the 
GP gender effect, which has rarely been investigated as 
reflected by a scarcity of relevant publications.
A limitation of the study is that we were not able to 
monitor the changes over time due to the cross-sectional 
design.
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Table 4 Influence of female gender of GPs (OR, 95% CIs, robust standard errors) on the primary healthcare indicators 
according to multilevel logistic regression analysis controlled for age of GP, age and gender of the patients, relative education 
of patients, practice size, types of settlement and regional location of GMP in 2016 and the ICC of tested models
Indicators OR 95% CI Robust SE
ICC 
(%)
Influenza immunisation (over 65 years) 1.03 0.98 to 1.09 0.028 17.9
Mammography screening (age 45–65 years) 1.05 1.03 to 1.08 0.014 4.8
Serum creatinine measurement 1.14 1.12 to 1.17 0.014 4.1
Lipid measurement 1.14 1.11 to 1.16 0.014 4.6
Beta-blocker application 0.98 0.96 to 1.01 0.013 2.4
HbA1c measurement 1.18 1.14 to 1.23 0.022 8.4
Eye examination 1.06 1.03 to 1.08 0.013 3.3
Management of COPD 1.05 1.01 to 1.09 0.019 4.9
Composite indicator 1.08 1.07 to 1.10 0.008 1.8
Reference group is male GPs.
COPD, chronic obstructive pulmonary disease; GMP, general medical practice; GPs, general practitioners; HbA1c, haemoglobin A1c; ICC, 
intraclass correlation coefficient.
Table 5 Number of observed and expected care events in 2016, with absolute differences and attributable proportion 
estimations (with 95% CI) in Hungary among 3 762 869 patients provided by male GPs
Indicators
Number of 
observed 
cases
Number of 
expected 
cases
Absolute 
difference Attributable proportion
Influenza immunisation 172 150 173 813 −1 663 0.97% (0.49%–1.44%)
Screening mammography 304 907 318 192 −13 285 4.36% (4%–4.71%)
Serum creatinine measurement 814 819 866 949 −52 130 6.4% (6.18%–6.61%)
Lipid measurement 752 737 812 459 −59 723 7.93% (7.71%–8.16%)
Beta-blocker application 48 202 47 037 1 165 2.42% (1.53%–3.31%)
HbA1c measurement 192 370 202 170 −9 801 5.09% (4.65%–5.54%)
Eye examination 95 617 103 302 −7 686 8.04% (7.4%–8.67%)
Management of COPD 75 154 76 901 −1 748 2.33% (1.61%–3.04%)
Total (composite indicator) 2 455 956 2 600 827 −144 871 5.9% (5.77%–6.02%)
COPD, chronic obstructive pulmonary disease; GPs, general practitioners; HbA1c, haemoglobin A1c.
The relative educational level, which was used to indicate 
the educational attainment for GMPs, cannot be considered 
as a year-specific and GMP-specific indicator. The informa-
tion on education was not available for the investigated year, 
and the relative educational level of the adults living in the 
settlement (settlement-specific) was considered, regardless 
of the number of GPs in one settlement.
Additionally, the fact that the range of variables in 
the NIHIFM database which could be included in the 
analysis is limited, careful interpretation is required. 
Although the analyses were controlled for GPs’ and 
patients’ age and gender, educational attainment, GMP 
practice size, types of settlement and regional location, 
there were confounding factors that were not included in 
our models, limiting the reliability of the presented risk 
measures. Selection of the GP may be affected by patients 
preferences and expectations, as patients have free 
choice of healthcare provider in Hungary. Since most 
of the GPs in Hungary are self-employed workers organ-
ising the provision on their own authority, the length of 
their working hours, the length of the consultation time 
and the availability of support staff were not measurable. 
The availability of support staff in solo practices or work 
in group practice could be an important factor in deter-
mining whether and how a patient will be treated.
Our analysis, which was based on data on solo GP prac-
tices, may differ from findings in group GP practices where 
professional cooperation with other providers may mitigate 
the effects of any non-clinical factors (eg, gender of GP).
Further research need
Our findings on impact of GP gender (mainly for HbA1c, 
serum creatinine and lipid measurement) suggest that 
further consideration of the effect is needed to identify 
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the details and mechanisms behind the gender effect to 
improve the adequacy of targeted interventions. Patients 
with early stage diabetes mellitus are more cooperative 
with female GPs, but patients with advanced stages of the 
disease, realising the seriousness of the consequences, are 
more sensitive to male GP directions. The onset/duration 
of a chronic disease and accordingly the complex needs of 
patients may modify the gender effect.46 Therefore, it would 
be worthwhile to investigate the potential influences on 
performance indicators that are differentiated according 
to the preferences47–49 and type of their health problem.50
Furthermore, there is a possible extension of our 
presented investigation. Analysing outcome indicators on 
the prognosis of patients with chronic diseases in PHC 
is obviously required to more convincingly describe the 
public health impact of the GP gender effect.
Implications
Poor-quality healthcare services put a great burden on 
payers and society everywhere.51 The effective utilisation 
of experiences of high-income countries52 addressing 
gender differences in provision is crucial in low-income and 
middle-income countries such as Hungary. High-quality 
PHC is a shared goal of the patients, the GPs and the state.
According to our observations, a possible way to 
improve the quality of PHC is to raise awareness about the 
significance of the GPs’ gender effect and its underlying 
causes. Keeping in mind that large sample size can detect 
even the smallest differences, the interpretation needs 
to consider that these small differences may have limited 
importance at population level; our results indicate the 
significance and urge the expansion of interventions 
aiming at improved communication skills of medical 
students and GPs, and at shifting the attitude of GPs. 
Incorporating practical knowledge on how the commu-
nication strategies and empathy in clinical practice influ-
ence the quality of services (which is often overlooked 
by medical students and practitioners) may facilitate the 
development of a patient-centred care culture.
It is well demonstrated that a behaviour change targeting 
improved patient outcomes is feasible by training physi-
cians and medical students.23 Since teaching patient-ori-
ented communication skills to medical students increases 
their competency, as well as patients’ satisfaction and 
health outcomes. Training in effective communication 
skills, embedded into the medical school curriculum, 
is widely recommended.53–56 Our results suggest that 
the scope of this training should be supplemented by 
gender-related attitudes and behavioural features.
These findings can be utilised in gender impact assess-
ment regarding the feminisation of the primary care 
physician workforce.57 58
COnCluSIOnS
Our results suggest the existence of a gender effect in 
Hungary on performance of GPs working in solo prac-
tices. Provision of guideline-recommended care was 
observed more often in patients of female GPs. The actual 
impact of the gender effect on the quality of services was 
found to be notable, emphasising that the communi-
cation style and attitude associated with female gender 
should be considered as factors influencing the quality 
of PHC and should be targeted accordingly in training 
of medical students and GPs. However, further studies 
involving a broader range of clinical and non-clinical 
factors are needed to allow more precise assessment of 
gender differences.
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